MonacoPro provides an exciting new way to enhance your clinical exam. The only ultra-widefield retinal imaging device with integrated Spectral Domain OCT, MonacoPro produces a 200° single shot optomap image in less than ½ second and also provides cross-sectional 40° OCT views of retinal structures. Engineered for efficiency, MonacoPro captures up to five imaging modalities for both eyes in just 90 seconds, optimising workflow, streamlining diagnostics, and delivering superior patient care.

optomap Image Modalities

• colour rg
• Sensory Retina
• Choroidal
• green af
• SD-OCT

Image Capture Features

• Non-Mydriatic, with minimum 2mm pupil1
• cSLO imaging through most cataracts2
• 3-in-1 Color DepthTM Imaging provides important clinical data from the retinal surface, through the choroid

Software Analysis Features

• OptosAdvanceTM Image Management software streamlines image review and consultations
• A comprehensive Reference Database (RDB) enables results of OCT analysis to be shown in relation to 1%, 5%, 95%, and 99% of the RDB population
• MonacoPro is equipped with AreaAssist, a tool designed to improve the efficiency of retinal imaging workflows by enabling users to automatically measure continuous areas of matching color and adjust the sensitivity of the selected area
• Distance (mm) and area (mm2) measurements provide objective assessment of change over time

Software Compliance Features

• MonacoPro includes robust cybersecurity enhancements to comply with ISO27032 guidelines and the FDA Cybersecurity in Medical Devices* requirement, providing enhanced protection against threats 
• General Data Protection Regulation (GDPR) compliant.
• DICOM-compatible software supports compliance with the Code of Federal Regulations3

1 Legarreta. Imaging of Peripheral Retina with Optos Ultra-Widefield Imaging: Evaluation of Aperture Size on Image Quality. ARVO 2012.
2 Friberg. Advances in retinal imaging of eyes with hazy media: Further Studies. ARVO 2011.
3 All Covered Entities must securely backup ‘retrievable exact copies of ePHI’ (CFR 164.308 (7)(ii)(A)).
*For US markets only